Saringosterol, a steroid isolated from Sargassum muticum, a brown edible alga widely distributed on the seashores of southern and eastern Korea, has been shown to exhibit anti-obesity effect. In this study, we investigated the anti-obesity activity of saringosterol through various experiments. The inhibitory effect of saringosterol on adipogenesis was evaluated via Oil Red O staining in 3T3-L1 preadipocytes. After confirming that saringosterol is not cytotoxic to these cells by using the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide assay, the effect of saringosterol on the expression of various adipogenesis-related genes was analyzed via quantitative realtime polymerase chain reaction and western blotting. We demonstrated that saringosterol dose dependently inhibited adipocyte differentiation and expression of adipogenic marker genes such as adipocyte fatty acidbinding protein, adiponectin, resistin, and fatty acid synthase in 3T3-L1 cells. In addition, saringosterol significantly inhibited the mRNA and protein expression of peroxisome proliferator-activated receptor γ and CCAAT enhancer-binding protein α in 3T3-L1 cells. Collectively, these findings indicate that saringosterol isolated from S. muticum exhibits anti-obesity effect by inhibiting the expression of adipogenic transcription factors and marker genes and that it may be developed as a drug to suppress adipogenesis.
INTRODUCTION
Obesity is a common metabolic disease caused by a combination of endocrine disorders, environmental factors, and genetic susceptibility. It is characterized by an excessive accumulation of fat in the body due to imbalance between energy intake and consumption and is usually associated with conditions such as diabetes, hypertension, hyperlipidemia, and cardiovascular diseases (Kopelman, 2000; Spiegelman and Flier, 2001; Vaneckova et al., 2014) . The impact of obesity on global public health has grown in recent years.
Adipocytes play an important role in energy homeostasis and lipid metabolism. The differentiation of preadipocytes into adipocytes is regulated by various hormones and transcription factors, as well as by the intracellular accumulation of fat (Spiegelman and Flier, 2001; Rosen and Spiegelman, 2006) . Peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT enhancer-binding protein α (C/EBPα) are crucial transcription factors in adipogenesis; PPARγ is a member of the PPAR subfamily of nuclear non-steroid hormone receptors, while C/EBPα is a leucine zipper transcription factor. They are highly expressed during the differentiation of preadipocytes into adipocytes (Tontonoz et al., 1994; Brun et al., 1996; Morrison and Farmer, 2000) and have been suggested as regulators of the expression of various proteins present in adipocytes, including adipocyte fatty acid-binding protein (aP2), adiponectin, resistin, and fatty acid synthase (FAS) (Lowell, 1999; Rosen et al., 2000; Jeon et al., 2004) .
Sargassum muticum is a brown edible alga that is widely distributed on the seashores of southern and eastern Korea. Previous studies have demonstrated that S. muticum has anti-oxidant, anti-bacterial, and antiinflammatory properties (Kim et al., 2007; Yoon et al., 2010; Chae et al., 2013) . Saringosterol, a steroid isolated from Sargassum sp., has been shown to inhibit the growth of Mycobacterium tuberculosis (Wachter et al., 2001) , as well as exhibit anti-obesity effect through its lipase inhibitory activity (Kim et al., 2014) . Furthermore, 24(S)-saringosterol has been reported as a cholesterollowering agent based on its liver X receptor-β agonist function (Chen et al., 2014) . However, there is no report to date on the anti-obesity effect of saringosterol involving PPARγ and C/EBPα expression with regard to adipogenesis.
In this study, we investigated whether saringosterol isolated from S. muticum exhibits inhibitory activity on adipocyte differentiation and adipogenic mediator expression in preadipocytes. Our results demonstrated that saringosterol reduced lipid accumulation and inhibited 3T3-L1 preadipocyte differentiation by suppressing the expression of PPARγ and C/EBPα.
MATERIALS AND METHODS
Preparation of S. muticum extract. Whole plants of S. muticum were provided by the Jeju Biodiversity Research Institute, Jeju, Republic of Korea, in September 2013. The identity of the plant material was established by one of the authors (Seong Su Hong), and a voucher specimen (G40) was deposited at the Bio-Center, Gyeonggido Business and Science Accelerator, Suwon-si, Republic of Korea. Dried whole plants (2 kg) were pulverized and extracted with EtOH (3 × 15 L) at room temperature (20-25°C) for 24 h.
Isolation and identification of saringosterol. The ethanol extract of S. muticum was filtered, concentrated in vacuo, suitably diluted with water, and partitioned with n-hexane, CH 2 Cl 2 , EtOAc, and n-BuOH. The CH 2 Cl 2 extract (14 g) was subjected to column chromatography over silica gel (n-hexane/CHCl 3 , 1:1 to 0:1; CHCl 3 /acetone, 70:1 to 2:1) to yield 11 fractions (G40-21-1-11). The G40-21-9 (499 mg) fraction was separated on a C 18 RP silica gel column (MeOH/H 2 O, 3:7 to 1:0) to afford 11 subfractions (G40-25-1-11). Subfraction G40-25-1 (208 mg) was further purified via preparative HPLC (Shimadzu, Kyoto, Japan) by eluting with MeOH/H 2 O (78:22) at 12 mL/min to yield saringosterol (23.1 mg). Its NMR spectra were recorded on a Bruker Ascend III 700 spectrometer (Bruker, Rheinstetten, Germany) using tetramethylsilane as an internal standard, with chemical shifts expressed in δ. Electrospray ionization mass spectra were obtained with a LTQ Orbitrap XL mass spectrometer (Thermo Scientific, Waltham, MA, USA). + . The structure of saringosterol is presented in Fig. 1A (Sheu and Sung, 1991) .
Apparatus and chromatographic conditions. HPLC analysis was performed on a Waters Alliance (Waters Co., Milford, MA, USA) system composed of a 2998 photodiode array detector and e2695 separation module. The separation was achieved using a YMC-Triart C18 column (250 × 4.6 mm ID, 5 μm particle size) (YMC Co., Ltd., Kyoto, Japan). The mobile phase consisted of water-trifluoroacetic acid (99.95:0.05; v/v) (solvent A) and acetonitrile (solvent B). The elution was performed using the following gradient: initial 10:90 (A:B v/v); 20 min 0:100 (A:B v/v); 30 min 0:100 (A:B v/v). The mobile phase was prepared daily, filtered through a 0.45 mm, WTP 0.5 mm membrane (Whatman, Maidstone, UK), sonicated before use, and delivered at a flow rate of 1.0 mL/min. The injection volume was 20 μL, and the column temperature was at 30°C. All the operations, the acquiring and analysis of data, were controlled by Empower ™ 3 software (Waters Co., Milford, MA, USA). The HPLC chromatogram data including saringosterol is presented in Fig. 1B . And HPLC chromatogram data and 13 C-NMR spectrum data of saringosterol are shown Fig. 1C and D, respectively.
Cell culture and adipocyte differentiation. Mouse 3T3-L1 cells were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA). The cells were maintained in Dulbecco's modified Eagle's medium (DMEM; ATCC) containing 10% bovine calf serum, 100 U/mL penicillin, and 0.1 mg/mL streptomycin (Invitrogen, Carlsbad, CA, USA), in a humidified atmosphere of 5% CO 2 at 37°C. Two days after the cells reached confluence, they were incubated with MDI (1 μΜ dexamethasone (Calbiochem, Billerica, MA, USA), 0.5 mM 3-isobutyl-1-methylxanthine (IBMX; Calbiochem), and 1 μg/mL insulin (Sigma-Aldrich, St. Louis, MO, USA)) in DMEM containing 10% fetal bovine serum (FBS; ATCC). On day 2, the medium was changed to DMEM containing 1 μg/mL insulin and 10% FBS. The progression medium was then changed to DMEM containing 10% FBS every 2 days (days 4 and 6). The cells were treated with different concentrations of saringosterol from days 0 to 8.
Oil Red O staining. Eight days after induction of adipocyte differentiation, 3T3-L1 cells were washed with phosphate-buffered saline (PBS), fixed with 3.7% formaldehyde in PBS for 30 min, and washed twice with PBS and 70% ethanol. The cells were then stained with Oil Red O (Sigma-Aldrich) in isopropyl alcohol/distilled water for 30 min and washed with 70% ethanol and PBS. Stained lipid droplets were observed with a microscope (TE2000-U; Nikon, Tokyo, Japan) and dissolved in isopropyl alcohol containing 4% Nonidet P-40 (Sigma-Aldrich) before quantification with a microplate reader (SpectraMax 190PC; Molecular Devices, Sunnyvale, CA, USA) at 510 nm.
Measurement of triglyceride contents and glycerol release. 3T3-L1 adipocytes were incubated in the presence of saringosterol at concentrations of 50, 100, and 200 μM in 24-well plates during 8 days after the initiation of differentiation. Triglyceride (TG) contents were determined using triglyceride assay kit according to the manufacturer's instructions (Zen-Bio, Research Triangle Park, NC, USA) with a microplate reader at 540 nm. And glycerol release levels were measured using the free glycerol assay kit according to the manufacturer's protocol (BioVision, Milpitas, CA, USA). The differentiated 3T3-L1 cells treated in DMEM with saringosterol of 50, 100, and 200 μM for 24 h. The media were collected and assayed for glycerol with a microplate reader at 570 nm.
Cell viability assay. 3T3-L1 cell viability was determined using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT; Duchefa Biochemie, Haarlem, The Netherlands) assay. Cells were plated on 96-well plates at a density of 5 × 10 3 cells per well in culture medium. After 24 h, a time zero control plate was made.
Saringosterol (12.5-200 μM) was applied directly, and the cells were incubated for 24 h in a humidified 5% CO 2 atmosphere at 37°C. The MTT solution (5 mg/mL in PBS) was then added to each well, followed by incubation for 3 h. The medium was removed from the wells by aspiration. Subsequently, 0.1 mL of buffered dimethyl sulfoxide was added to each well, and the plate was shaken to dissolve the formazan. Absorbance was measured with a microtiter plate reader at 540 nm.
RNA isolation and quantitative real-time PCR analysis. Differentiated 3T3-L1 cells were harvested and washed with PBS. Total RNA was extracted using Trizol reagent (Invitrogen) and quantified with a spectrophotometer (SD2000; Bioprince ™ Technology Development Co., Seoul, Korea) by measuring the absorbance at 260 and 280 nm. cDNA synthesis was performed using 1 μg of total RNA with the SuperScript® III first-strand synthesis system (Invitrogen). The synthesized cDNA was amplified using specific primers with the SYBR Premix Ex Taq system (TaKaRa, Shiga, Japan). The primers used in the experiments are shown in Table 1 . Glyceraldehyde 3-phosphate dehydrogenase was used as the invariant control.
Western blot analysis. 3T3-L1 cells were lysed on ice for 30 min in RIPA buffer containing a cocktail of protease inhibitors (Sigma-Aldrich). The cells were centrifuged at 16,000g for 30 min at 4°C to obtain the supernatant. The cell lysates (50 μg) were separated on an 8% SDS polyacrylamide gel and transferred onto nitrocellulose membranes (Whatman, St. Louis, MO, USA). Protein expression was analyzed by immunoblotting with antibodies against PPARγ, C/EBPα (1:1000; Cell Signaling Technology, Danvers, MA, USA), and β-actin (1:1000; Cell Signaling Technology). Horseradish peroxidaseconjugated anti-rabbit antibodies (1:5000; Cell Signaling Technology) were used as secondary antibodies. The proteins were detected with SuperSignal® West Pico chemiluminescent substrate (Thermo Scientific) using the Amersharm Imager 600 (GE Healthcare Life Sciences, Chicago, IL, USA).
Statistical analysis. Data are expressed as means ± standard deviation (SD). Experimental results were analyzed for statistical significance using Student's t-test and one-way analysis of variance. Values of *p < 0.05 and **p < 0.01 were considered statistically significant.
RESULTS

Effects of saringosterol on cell viability and lipid accumulation in 3T3-L1 cells
We first examined the cytotoxicity of saringosterol in 3T3-L1 cells. The cells were treated with increasing doses (12.5-200 μM) of saringosterol, and cell proliferation was determined using MTT assay. The different concentrations of saringosterol were not cytotoxic to 3T3-L1 cells (Fig. 2A) . Subsequently, the inhibitory effect of saringosterol on adipocyte differentiation was assessed using MDI differentiation medium (containing dexamethasone, IBMX, and insulin) to induce the differentiation of 3T3-L1 preadipocytes. After 8 days, cells treated with 50, 100, and 200 μM saringosterol were stained with Oil Red O and observed under a microscope. Saringosterol treatment significantly suppressed adipocyte differentiation in a dose-dependent manner. Lipid droplet accumulation in 3T3-L1 adipocytes treated with 50, 100, and 200 μM saringosterol decreased to 56.5, 47.3, and 26.6%, respectively, relative to that in untreated cells ( Fig. 2B and C) . Also, TG contents were observed in 3T3-L1 cells (Fig. 2D) . TG accumulation was reduced with 50, 100, and 200 μM of saringosterol compared with differentiated adipocytes. We determined the effect of saringosterol on glycerol release in the media of 3T3-L1 cells. As shown in Fig. 2E , saringosterol increased glycerol release levels in 3T3-L1 cells. These results clearly indicate that saringosterol isolated from S. muticum inhibited lipid and TG accumulation and induced glycerol secretion in 3T3-L1 cells in a dose-dependent manner, without inducing cytotoxicity.
Effect of saringosterol on the expression of PPARγ and C/EBPα at mRNA and protein levels in 3T3-L1 cells Both PPARγ and C/EBPα play important roles in cellular responses related to lipid accumulation and adipocyte differentiation (Gregoire et al., 1998; Rosen et al., 2002) . In view of the inhibitory activity of saringosterol on adipocyte differentiation, we examined the expression of PPARγ and C/EBPα in 3T3-L1 cells using Table 1 . Primer sequences used for real-time PCR
Target
Primer sequences Accession no.
quantitative real-time PCR and western blot. As shown Fig. 3 , saringosterol treatment significantly inhibited the expression of PPARγ and C/EBPα at the mRNA level in 3T3-L1 cells. Likewise, we confirmed that saringosterol also suppressed the expression of PPARγ and C/EBPα at the protein level in these cells (Fig. 4A and B) . Furthermore, the inhibitory effect of saringosterol on the protein expression of PPARγ and C/EBPα was very similar in pattern to that of its inhibition of the mRNA expression of PPARγ and C/EBPα (Figs. 3 and 4) .
Effect of saringosterol on the expression of adipogenic marker genes in 3T3-L1 cells
During 3T3-L1 adipocyte differentiation, PPARγ and C/EBPα regulate the expression of various genes involved in adipogenesis (Rosen et al., 2000; Jeon et al., 2004) . Therefore, we investigated the effect of saringosterol on the expression of adipogenic marker genes encoding the proteins aP2, adiponectin, resistin, and FAS. On day 8, fully differentiated adipocytes were treated with 100 and 200 μM saringosterol, and their mRNA expression was analyzed using quantitative real-time PCR. As shown in Fig. 5 , saringosterol treatment effectively inhibited mRNA expression of aP2, adiponectin, resistin, and FAS. These findings suggest that saringosterol prevents adipocyte differentiation and lipid accumulation through suppression of adipogenic-related marker genes.
DISCUSSION
In our preliminary study, we examined the antiobesity effect of the ethanol extract of S. muticum and showed that it dose dependently inhibited lipid accumulation in 3T3-L1 cells based on Oil Red O staining result (data not shown). Isolation of the active compound from this extract led to the identification of saringosterol. Saringosterol has also previously been isolated from other seaweeds such as S. fusiform, Lessonia nigrescens, and S. thunbergii (Wachter et al., 2001; Kim et al., 2014; Xu et al., 2001) . Until recently, previous investigation about saringosterol has mainly reported on its lipase inhibitory activity with regard to its anti-obesity effect (Kim et al., 2014) . In the present study, we assessed the anti-adipogenic effect of saringosterol in preadipocytes. First, we showed that saringosterol reduced lipid and TG contents in 3T3-L1 cells during adipocyte differentiation without inducing cytotoxicity. And we observed that saringosterol increased the glycerol release in 3T3-L1 adipocyte (Fig. 2) . This finding led us to investigate its effect on the expression of transcription factors associated with adipogenesis. The transcription factors PPARγ and C/EBPα are crucial in the process of cell differentiation by which preadipocytes become adipocytes; PPARγ stimulates lipoprotein lipase expression and promotes fatty acid uptake, while C/EBPα induces terminal adipocyte differentiation. These two factors remain elevated during the rest of the differentiation process and life of the mature adipocyte (Brun et al., 1996; Morrison and Farmer, 2000; Rosen, 2005) . Accordingly, many reports have associated suppression of adipocyte differentiation with the downregulation of PPARγ and/or C/EBPα (Tontonoz et al., 1995; Kang et al., 2003; Farmer, 2005; Ahn et al., 2012) .
In the present study, we demonstrated the inhibitory effect of saringosterol on the expression of PPARγ and C/EBPα at mRNA (Fig. 3) and protein (Fig. 4 ) levels in fully differentiated 3T3-L1 cells and showed that the inhibition of mRNA and protein expression of PPARγ and C/EBPα followed a similar pattern (Figs. 3 and 4) . In addition, saringosterol treatment decreased the mRNA expression of adipocyte-specific genes such as aP2, adiponectin, resistin, and FAS (Fig. 5) . The induction of aP2 is linked with PPARγ activation in fat cells, and together with adiponectin, they are both detected in the adipose tissue during adipocyte differentiation (Tontonoz et al., 1994; Glatz et al., 1995) . Resistin is a polypeptide secreted by adipocytes that is involved in the regulation of glucose homeostasis, while FAS is a crucial enzyme in fatty acid synthesis (Steppan et al., 2001; Rajala et al., 2003; Sul and Wang, 1998) . Thus, inhibition of the expression of these molecules is associated with anti-obesity activity.
In conclusion, this is the first report to demonstrate that saringosterol isolated from S. muticum inhibited adipocyte differentiation via downregulation of PPARγ, C/EBPα, and adipogenic marker genes such as aP2, adiponectin, resistin, and FAS. These findings suggest that saringosterol may be developed as a drug candidate for the prevention of obesity-related diseases. 
